Page last updated: 2024-09-05

dabigatran and Embolism, Pulmonary

dabigatran has been researched along with Embolism, Pulmonary in 103 studies

Research

Studies (103)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (1.94)	29.6817
2010's	84 (81.55)	24.3611
2020's	17 (16.50)	2.80

Authors

Authors	Studies
Emmens, W; Mitrovic, D; Naimi, A; van den Bemt, P; van der Mijle, A; van Roon, E; Veeger, N	1
Bloom, B; Cohen-Aubart, F; Freund, Y	1
Antoniolli, M; Barrionuevo, B; Bernal, MI; Cigalini, IM; Lerech, E; Morcos, L; Scatularo, CE; Zaidel, EJ	1
Albiges, L; Baudin, E; Besse, B; Boileve, A; Ducreux, M; Hadoux, J; Leary, A; Malka, D; Maulard, A; Mir, O; Rieutord, A; Scotté, F	1
Hui, X; Li, J; Li, M; Ma, Y; Tian, J; Wang, Q; Wang, X; Xie, P; Yan, P; Yang, K; Yao, L	1
Alghamdi, B; Alhuwail, A; Alkhathami, S; Alkredees, M; Almalki, T; AlNasser, M; Alotaibi, W; Alqahtani, B; Alsaeed, O; Alsalem, T; Alshahrani, F; Alshreem, A; Alzahrani, Y; Asiri, A; Assiri, A; Ayoub, M; Bakkari, A; Basndwah, H; Ibrahim, ARN; Khudari, A; Mustafa, M; Sultan, H; Tawhari, F; Zaitoun, M	1
Buscarini, E; Coote, N; Droege, F; Dupuis-Girod, S; Fialla, AD; Geisthoff, U; Kjeldsen, A; Lenato, GM; Mager, HJ; Manfredi, G; Millar, CM; Pagella, F; Post, MC; Sabbà, C; Shovlin, CL; Suppressa, P; Sure, U; Torring, PM; Ugolini, S	1
Carleton, O; Smith, FM; Towns, C	1
Albert, L; Bejjani, A; Coons, JC; Iasella, CJ	1
Devilbiss, Z; O'Connor, F	1
Choi, S; Hwang, KT; Jeong, SY; Koo, JW; Lee, JK; Park, KC	1
Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I	1
Hofmann, ER; Isaacs, DJ; Johnson, EJ; Rangarajan, S; Vinson, DR	1
Oh, HJ; Park, BJ; Ryu, KH; Yoon, BH	1
D'Elia, E; Di Marco, F; Falanga, A; Gori, M; Grosu, A; Iorio, A; Lorini, FL; Senni, M	1
Jeon, SH; Kim, MS; Kwon, GH	1
Brodmann, M; Gary, T; Muster, V; Raggam, RB; Wölfler, A	1
Ageno, W; Barco, S; Bouvaist, H; Brodmann, M; Couturaud, F; Cuccia, C; Dellas, C; Dimopoulos, K; Duerschmied, D; Empen, K; Faggiano, P; Ferrari, E; Galiè, N; Galvani, M; Ghuysen, A; Giannakoulas, G; Huisman, MV; Jiménez, D; Klok, FA; Konstantinides, SV; Kozak, M; Lang, IM; Lankeit, M; Mavromanoli, AC; Meneveau, N; Meyer, G; Münzel, T; Palazzini, M; Petris, AO; Piovaccari, G; Salvi, A; Schellong, S; Schmidt, KH; Schmidtmann, I; Toenges, G; Verschuren, F	1
Ageno, W; Casella, IB; Chee, KH; Goldhaber, SZ; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I	1
Cifu, AS; Jain, A	1
Nasir, U	1
Chenoweth, JA; Holmes, JF; Johnson, MA; Nishijima, DK; Shook, L; Sutter, ME	1
Albisetti, M; Biss, B; Bomgaars, L; Brueckmann, M; Gropper, S; Halton, JML; Harper, R; Huang, F; Luciani, M; Maas, H; Mitchell, LG; Tartakovsky, I	1
Chu, XC; Gao, JH; Ning, B; Wang, LL; Zhao, CX	1
Ageno, W; Barco, S; Binder, H; Brenner, B; Duerschmied, D; Empen, K; Faggiano, P; Ficker, JH; Galiè, N; Ghuysen, A; Held, M; Heydenreich, N; Huisman, MV; Jiménez, D; Klok, FA; Konstantinides, SV; Kozak, M; Lang, IM; Lankeit, M; Meyer, G; Münzel, T; Petris, A; Pruszczyk, P; Quitzau, K; Schellong, S; Schmidt, KH; Stefanovic, BS; Verschuren, F; Wolf-Puetz, A	1
Avorn, J; Choudhry, NK; Gagne, JJ; Glynn, RJ; Krumme, AA; Kulldorff, M; Ortiz, AS; Pawar, A; Schneeweiss, S	1
Hu, Y; Tang, L; Zhang, Z	1
Steurer, J	1
Howard, LS	1
Banica, A; Benoit, B; Delisle, J; Fernandes, JC; Laflamme, GY; Malo, M; Nguyen, H; Ranger, P; Senay, A; Trottier, M	1
Alves, JL; Fernandes, CJC; Gavilanes-Oleas, FA; Hoette, S; Jardim, C; Morinaga, L; Prada, LFL; Salibe Filho, W; Souza, R; Terra Filho, M	1
Barden, S; Campbell, T; Condliffe, R; Connolly, V; Davies, CWH; Donaldson, J; Everett, B; Free, C; Horner, D; Howard, LSGE; Hunter, L; Kaler, J; Nelson-Piercy, C; O-Dowd, E; Patel, R; Preston, W; Sheares, K	1
Azboy, I; Groff, H; Parvizi, J	1
Carrier, M; Khorana, AA; Lee, AYY; Meyer, G; Noble, S; O'Connell, C; Soff, G	1
Friedecky, D; Hlusi, A; Lukes, J; Nemcova, M; Palova, M; Prochazkova, J; Slavik, L; Ulehlova, J; Vaclavik, J; Zhanelova, M	1
Antunovic, M; Dzudovic, B; Dzudovic, J; Obradovic, S; Stavric, M; Subota, V; Subotic, B	1
Alvarez-Madrazo, S; Bennie, M; Mueller, T; Robertson, C; Wu, O	1
Cassese, A; Cimmino, G; Cioppa, ND; Gallinoro, E; Golino, P; Magliocca, MCG; Papa, AA; Rago, A; Sperlongano, S	1
Arcadi, FA; Calabrò, RS; Casella, C; Genovese, C; Giorgianni, R; Marino, S; Naro, A; Portaro, S	1
Guijarro Merino, R; Villalobos Sánchez, A	1
Kujawski, SZ; Prom, R; Rafferty, JA	1
Holley, AB; King, CS; Moores, LK	1
Callréus, T; Due, KM; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F	1
Bates, P; Culpan, P; El-Daly, I; Reidy, J	1
Wanat, MA	1
Agnelli, G; Becattini, C; Franco, L	1
Eriksson, BI; Quinlan, DJ	1
Cohen, AA; Rider, T	1
Adam, SS; Lachiewicz, PF; McDuffie, JR; Ortel, TL; Williams, JW	1
Atar, D; Ghanima, W; Sandset, PM	1
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V	1
Wood, P	1
Bounameaux, H; Fontana, P; Goldhaber, SZ	1
Ansell, J; Mantha, S	1
Chatterjee, S; Ghosh, J; Giri, JS; Mukherjee, D; Sardar, P	1
Akwaa, F; Spyropoulos, AC	1
Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Amin, A; Bruno, A; Lin, J; Lingohr-Smith, M; Trocio, J	1
Bultas, J; Karetová, D	1
Cattaneo, M; Lussana, F; Squizzato, A	1
Karbyshev, IA; Petrikov, AS; Shoikhet, YN; Vyatkin, DA; Zakharchenko, KK	1
Law, EH; Leung, TS	1
Bächli, E; Walti, C	1
Beinema, MJ; Brouwers, JR; Jansman, FG; Postma, MJ; Stevanović, J; van Leent, MW	1
Jugrin, AV; Lamotte, M; Sunderland, T; Urbich, M; Ustyugova, A	1
De Francesco, M; Hösel, V; Jugrin, AV; Lamotte, M; Sunderland, T; Ustyugova, A	1
Condliffe, R; Elliot, CA; Hurdman, J; Kiely, DG; Maclean, RM; Quadery, R; Sabroe, I; van Veen, JJ	1
Gross, PL; Ni, R; Saldanha, LJ; Shaya, SA; Vaezzadeh, N; Zhou, J	1
Ageno, W; Bauersachs, R; Couturaud, F; Décousus, H; Mismetti, P	1
Anto-Michel, N; Bode, C; Diehl, P; Geisen, U; Meyer, M; Moser, M; Olivier, CB; Weber, S; Weik, P; Zhou, Q	1
Gonzalez, MG; Levy, PD; Peacock, WF; Than, M	1
Kesteven, P; McCaslin, JE; Robertson, L	1
Roca, B; Roca, M	1
Armstrong, J; Pascu, O; Ridgley, J; Vlad, I	1
Stiefelhagen, P	1
Johnson, D; Northup, A; Senfield, J; Wiggins, BS	1
Dobesh, PP; Finks, SW; Trujillo, TC	1
Agnelli, G; Becattini, C	1
Eriksson, H; Feuring, M; Fraessdorf, M; Goldhaber, SZ; Kakkar, A; Kreuzer, J; Schellong, S; Schulman, S	1
Hansrani, V; Khanbhai, M; McCollum, C	1
Koyfman, A; Long, B	1
Kang, J; Lee, JH; Lee, JS; Lee, KM	1
Ageno, W; Casella, IB; Desch, M; Goldhaber, SZ; Han, CK; Kimura, K; Raskob, GE; Schellong, S; Schulman, S; Singer, DE; Tang, W	1
Albers, L; Bolt, J; Duffy, P; Hager, N; Semchuk, W; Wojcik, W	1
Broscaru, L; Gulba, DC	1
Eriksson, H; Feuring, M; Goldhaber, SZ; Hantel, S; Kakkar, AJ; Kreuzer, J; Schellong, S; Schueler, E; Schulman, S	1
Cangemi, DJ; Cipher, DJ; Feagins, LA; Krill, T; Spechler, SJ; Weideman, R	1
Felix, SB; Greinacher, A; Hammer, F; Selleng, K; Wernicke, S	1
Lowenthal, DT; Sattari, M	1
Oliver, M	1
Kwok, CS; Loke, YK	1
Guay, DR	1
Keltai, K; Keltai, M	1
Galanis, T; Kraft, WK; Merli, GJ	1
Combe, S; Conard, J; Flaujac, C; Horellou, MH; Samamaa, MM	1
Büller, HR; Combe, S	1
Best, M; Jones, QC; Palmer, K; Wathen, CG	1
Betegón Nicolás, L; de Salas-Cansado, M; Gómez Arrayas, I; Gómez Cerezo, JF; Rubio-Terrés, C; Suárez Fernández, C	1
Hampton, T	1
Nendaz, M; Perrier, A	1

Reviews

36 review(s) available for dabigatran and Embolism, Pulmonary

Article	Year
Acute Pulmonary Embolism: A Review. JAMA, 2022, 10-04, Volume: 328, Issue:13 Topics: Acute Disease; Administration, Oral; Anticoagulants; Dabigatran; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Pulmonary Embolism; Risk; Rivaroxaban; United States; Vitamin K; Warfarin	2022
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. The Cochrane database of systematic reviews, 2023, 04-14, Volume: 4 Topics: Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasm Recurrence, Local; Pulmonary Embolism; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis	2023
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: A network meta-analysis. Medicine, 2021, Mar-19, Volume: 100, Issue:11 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin	2021
Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis. Medicine, 2017, Volume: 96, Issue:40 Topics: Anticoagulants; Arthroplasty; Azetidines; Benzylamines; Dabigatran; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin	2017
Progress in the research on venous thromboembolism. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017, Volume: 37, Issue:6 Topics: Anticoagulants; Blood Coagulation Factors; Computed Tomography Angiography; Dabigatran; Genetic Predisposition to Disease; Heparin; Humans; Phlebography; Practice Guidelines as Topic; Pulmonary Embolism; Pyridines; Quality of Life; Recurrence; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2017
Non-vitamin K antagonist oral anticoagulants for pulmonary embolism: who, where and for how long? Expert review of respiratory medicine, 2018, Volume: 12, Issue:5 Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism	2018
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE). Thorax, 2018, Volume: 73, Issue:Suppl 2 Topics: Ambulatory Care; Anticoagulants; Dabigatran; Female; Hemorrhage; Humans; Length of Stay; Male; Neoplasms; Patient Discharge; Patient Selection; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Substance Abuse, Intravenous; Thiazoles	2018
[Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants]. Medicina clinica, 2012, Volume: 139 Suppl 2 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism	2012
Moving toward a more ideal anticoagulant: the oral direct thrombin and factor Xa inhibitors. Chest, 2013, Volume: 143, Issue:4 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin	2013
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations. Injury, 2013, Volume: 44, Issue:12 Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism	2013
Novel oral anticoagulants: a review of new agents. Postgraduate medicine, 2013, Volume: 125, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
New oral anticoagulants for the treatment of venous thromboembolism. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin	2013
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin	2013
NOACs for thromboprophylaxis in medical patients. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Enoxaparin; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Warfarin	2013
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Annals of internal medicine, 2013, Aug-20, Volume: 159, Issue:4 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis	2013
New oral anticoagulants--a review. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Oct-01, Volume: 133, Issue:18 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. European journal of internal medicine, 2014, Volume: 25, Issue:1 Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin	2014
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. European heart journal, 2014, Jul-21, Volume: 35, Issue:28 Topics: Acute Disease; Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Long-Term Care; Morpholines; Perioperative Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism; Vitamin K	2014
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism. Journal of thrombosis and thrombolysis, 2015, Volume: 39, Issue:2 Topics: Acute Disease; Adult; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Survival Analysis; Thiazoles; Venous Thrombosis	2015
Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clinic proceedings, 2014, Volume: 89, Issue:7 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism	2014
The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism. Current medical research and opinion, 2014, Volume: 30, Issue:11 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty. Thrombosis and haemostasis, 2015, Volume: 114, Issue:2 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2015
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran. Drug design, development and therapy, 2015, Volume: 9 Topics: Anticoagulants; Antithrombins; Dabigatran; Hemorrhage; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis	2015
[Direct acting oral anticoagulants in venous thromboembolism]. Praxis, 2015, Jul-22, Volume: 104, Issue:15 Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Contraindications; Dabigatran; Drug Interactions; Humans; International Normalized Ratio; Male; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Thiophenes; Venous Thromboembolism	2015
Treatment of pulmonary embolism. Presse medicale (Paris, France : 1983), 2015, Volume: 44, Issue:12 Pt 2 Topics: Antithrombins; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Venous Thromboembolism	2015
Target-specific Oral Anticoagulants in the Emergency Department. The Journal of emergency medicine, 2016, Volume: 50, Issue:2 Topics: Acute Disease; Administration, Oral; Anticoagulants; Blood Coagulation Tests; Dabigatran; Drug Interactions; Drug Monitoring; Emergency Service, Hospital; Factor Xa Inhibitors; Hemorrhage; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism	2016
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. The Cochrane database of systematic reviews, 2015, Dec-04, Issue:12 Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2015
The new oral anticoagulants: Reasonable alternatives to warfarin. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:12 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis	2015
Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:6 Topics: Administration, Oral; Anticoagulants; Dabigatran; Drug Interactions; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2016
Treatment of Venous Thromboembolism With New Anticoagulant Agents. Journal of the American College of Cardiology, 2016, Apr-26, Volume: 67, Issue:16 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Infusions, Intravenous; Male; Middle Aged; Phlebography; Prognosis; Pulmonary Embolism; Pyridines; Randomized Controlled Trials as Topic; Rivaroxaban; Severity of Illness Index; Survival Analysis; Thiazoles; Treatment Outcome; Venous Thromboembolism	2016
The Prevention of Venous Thromboembolism in Surgical Patients. Advances in experimental medicine and biology, 2017, Volume: 906 Topics: Age Factors; Anticoagulants; Communicable Diseases; Dabigatran; Dehydration; Fondaparinux; Heparin, Low-Molecular-Weight; Hormone Replacement Therapy; Humans; Neoplasms; Obesity; Polysaccharides; Primary Prevention; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thromboembolism; Venous Thrombosis	2017
Best Clinical Practice: Current Controversies in Pulmonary Embolism Imaging and Treatment of Subsegmental Thromboembolic Disease. The Journal of emergency medicine, 2017, Volume: 52, Issue:2 Topics: Anticoagulants; Dabigatran; Decision Making; Humans; Patient Outcome Assessment; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Thiazoles; Tomography, X-Ray Computed; Venous Thromboembolism	2017
Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; United States; Venous Thrombosis	2011
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison. Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists? Hospital practice (1995), 2011, Volume: 39, Issue:1 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Drug Interactions; Heparinoids; Humans; Pulmonary Embolism; Pyridines; Stroke; Venous Thromboembolism; Vitamin K	2011
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Advances in surgery, 2011, Volume: 45 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis	2011

Trials

6 trial(s) available for dabigatran and Embolism, Pulmonary

Article	Year
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial. The Lancet. Haematology, 2021, Volume: 8, Issue:9 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Drug Administration Schedule; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pulmonary Embolism; Risk Factors; Treatment Outcome; Venous Thromboembolism	2021
Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:11 Topics: Administration, Oral; Age Factors; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; Dabigatran; Drug Compounding; Drug Monitoring; Female; Hemorrhage; Humans; Infant; Male; Pulmonary Embolism; Recurrence; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study. Thrombosis and haemostasis, 2017, Volume: 117, Issue:12 Topics: Acute Disease; Anticoagulants; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Hemorrhage; Heparin; Humans; Male; Prospective Studies; Pulmonary Embolism; Recurrence; Reference Standards; Research Design; Risk; Survival Analysis; Treatment Outcome; Young Adult	2017
Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients. Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Aged; Anticoagulants; Blood Coagulation Factors; Dabigatran; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thrombin; Treatment Outcome	2019
Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting. Journal of medical economics, 2016, Volume: 19, Issue:1 Topics: Anticoagulants; Cost-Benefit Analysis; Dabigatran; Double-Blind Method; Female; Health Services; Hemorrhage; Humans; Male; Middle Aged; Models, Econometric; Pulmonary Embolism; Quality-Adjusted Life Years; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis; Warfarin	2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II. Thrombosis and haemostasis, 2016, Sep-27, Volume: 116, Issue:4 Topics: Adult; Aged; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin	2016

Other Studies

61 other study(ies) available for dabigatran and Embolism, Pulmonary

Article	Year
Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020. Clinical drug investigation, 2022, Volume: 42, Issue:7 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pulmonary Embolism; Pyridones; Reproducibility of Results; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis; World Health Organization	2022
Predictors of use of direct oral anticoagulants in acute pulmonary embolism. Archivos de cardiologia de Mexico, 2022, Volume: 92, Issue:4 Topics: Acute Disease; Anticoagulants; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Pulmonary Embolism; Rivaroxaban	2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Dec-16, Volume: 31, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Bevacizumab; Dabigatran; Female; Hemorrhage; Humans; Neoplasms; Pulmonary Embolism; Retrospective Studies; Rivaroxaban	2022
Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort study. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:20 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Rivaroxaban; Saudi Arabia; Stroke; Tertiary Care Centers; Venous Thrombosis	2023
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet journal of rare diseases, 2019, 08-28, Volume: 14, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Epistaxis; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Telangiectasia, Hereditary Hemorrhagic; Venous Thromboembolism; Warfarin	2019
A rare provocation: a case of extensive pulmonary embolism in a man with previously undiagnosed Klinefelter Syndrome. The New Zealand medical journal, 2019, 09-20, Volume: 132, Issue:1502 Topics: Antithrombins; Blood Coagulation; Computed Tomography Angiography; Dabigatran; Genetic Testing; Humans; Infertility, Male; Klinefelter Syndrome; Lung; Male; Middle Aged; Physical Examination; Pulmonary Embolism; Risk Adjustment; Risk Factors; Testosterone	2019
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism. Pharmacotherapy, 2020, Volume: 40, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Cohort Studies; Dabigatran; Female; Humans; Male; Middle Aged; Obesity, Morbid; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Warfarin	2020
Pulmonary Embolism in a Collegiate Softball Athlete: A Case Report. Current sports medicine reports, 2020, Volume: 19, Issue:2 Topics: Anticoagulants; Antithrombins; Athletes; Baseball; Chest Pain; Computed Tomography Angiography; Dabigatran; Dyspnea; Female; Hemoptysis; Humans; Pulmonary Embolism; Warfarin; Young Adult	2020
Perioperative symptomatic venous thromboembolism after immediate chemoprophylaxis in patients with pelvic and lower-extremity fractures. Scientific reports, 2020, 03-25, Volume: 10, Issue:1 Topics: Adult; Aged; Anticoagulants; Bones of Lower Extremity; Chemoprevention; Dabigatran; Enoxaparin; Female; Fractures, Bone; Humans; Male; Middle Aged; Multidetector Computed Tomography; Pelvic Bones; Pulmonary Embolism; Risk Factors; Sex Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult	2020
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. The American journal of medicine, 2020, Volume: 133, Issue:8 Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries	2020
Primary care physicians comprehensively manage acute pulmonary embolism without higher-level-of-care transfer: A report of two cases. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Acute Disease; Adult; Ambulatory Care; Anticoagulants; Antithrombins; Chest Pain; Computed Tomography Angiography; Dabigatran; Decision Making, Shared; Dyspnea; Enoxaparin; Hospitalization; Humans; Male; Middle Aged; Myelitis, Transverse; Patient Transfer; Physicians, Primary Care; Pulmonary Embolism; Risk Assessment; Treatment Outcome; Venous Thrombosis	2020
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC pulmonary medicine, 2021, Mar-24, Volume: 21, Issue:1 Topics: Administration, Oral; Anticoagulants; COVID-19; Dabigatran; Drug Therapy, Combination; Heparin; Humans; Male; Middle Aged; Pulmonary Embolism; Recurrence; Warfarin	2021
Symptomatic bilateral massive pulmonary embolism and proximal and distal deep vein thrombosis following arthroscopic meniscus surgery: A case report. Medicine, 2021, Apr-02, Volume: 100, Issue:13 Topics: Adult; Anticoagulants; Arthroscopy; Dabigatran; Electrocardiography; Femoral Vein; Heparin, Low-Molecular-Weight; Humans; Male; Meniscus; Popliteal Vein; Postoperative Complications; Pulmonary Artery; Pulmonary Embolism; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis	2021
Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination. Lancet (London, England), 2021, 05-15, Volume: 397, Issue:10287 Topics: Anticoagulants; Antithrombins; ChAdOx1 nCoV-19; COVID-19 Vaccines; Dabigatran; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Pulmonary Embolism; Thrombocytopenia	2021
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. Journal of thrombosis and thrombolysis, 2022, Volume: 53, Issue:2 Topics: Anticoagulants; Dabigatran; Humans; Pulmonary Embolism; Venous Thromboembolism; Warfarin	2022
Antithrombotic Therapy for Venous Thromboembolic Disease. JAMA, 2017, 05-16, Volume: 317, Issue:19 Topics: Antithrombins; Dabigatran; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Review Literature as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2017
Pulmonary embolism in a morbidly obese patient receiving dabigatran. Clinical cardiology, 2017, Volume: 40, Issue:9 Topics: Antithrombins; Blood Coagulation; Body Mass Index; Dabigatran; Drug Substitution; Humans; Male; Middle Aged; Obesity, Morbid; Pulmonary Embolism; Risk Factors; Rivaroxaban; Treatment Failure	2017
Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran. The western journal of emergency medicine, 2017, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Head Injuries, Closed; Hospitals, University; Humans; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Prevalence; Pulmonary Embolism; Retrospective Studies; Stroke; Tomography, X-Ray Computed; Trauma Centers; Urban Population; Venous Thrombosis	2017
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:1 Topics: Anticoagulants; Antithrombins; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Venous Thrombosis; Warfarin	2018
Praxis, 2018, Volume: 107, Issue:3 Topics: Anticoagulants; Antithrombins; Clinical Trials as Topic; Dabigatran; Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Survival Analysis; Venous Thrombosis; Warfarin	2018
Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada. Vascular health and risk management, 2018, Volume: 14 Topics: Aged; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Enoxaparin; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Patient Discharge; Pulmonary Embolism; Quebec; Registries; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2018
Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension. Clinics (Sao Paulo, Brazil), 2018, 05-17, Volume: 73 Topics: Administration, Oral; Adult; Aged; Antithrombins; Chronic Disease; Dabigatran; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Reproducibility of Results; Treatment Outcome; Vitamin K	2018
Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty. The Journal of arthroplasty, 2018, Volume: 33, Issue:11 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Conflict of Interest; Dabigatran; Enoxaparin; Female; Fondaparinux; Health Care Sector; Hemorrhage; Humans; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism; Warfarin	2018
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:9 Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Factor Xa Inhibitors; Hemorrhage; Humans; Multicenter Studies as Topic; Neoplasms; Observational Studies as Topic; Patient Acceptance of Health Care; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2018
Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays. Clinical laboratory, 2018, Oct-01, Volume: 64, Issue:10 Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chromatography, Liquid; Dabigatran; Factor Xa Inhibitors; Humans; Partial Thromboplastin Time; Prothrombin Time; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Tandem Mass Spectrometry; Thrombin; Venous Thrombosis	2018
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland. British journal of clinical pharmacology, 2019, Volume: 85, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Scotland; Stroke; Treatment Outcome	2019
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2018, Volume: 37, Issue:3 Topics: Antithrombins; Dabigatran; Female; Humans; Middle Aged; Myotonic Dystrophy; Pulmonary Embolism	2018
New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report. Medicina (Kaunas, Lithuania), 2019, Mar-17, Volume: 55, Issue:3 Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antiphospholipid Syndrome; Antithrombins; Carotid Arteries; Computed Tomography Angiography; Dabigatran; Female; Follow-Up Studies; Humans; Product Surveillance, Postmarketing; Pulmonary Embolism; Stroke; Treatment Outcome; Venous Thrombosis; Warfarin	2019
Dabigatran "non-inferior" to warfarin, but only just. BMJ (Clinical research ed.), 2013, Feb-27, Volume: 346 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Pulmonary Embolism; Treatment Outcome; Venous Thrombosis; Warfarin	2013
Acute pulmonary emboli in a patient on long-term dabigatran therapy. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:4 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Pulmonary Embolism	2013
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. Journal of the American College of Cardiology, 2013, Jun-04, Volume: 61, Issue:22 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Denmark; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Intracranial Hemorrhages; Logistic Models; Male; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Pyridines; Registries; Stroke; Warfarin	2013
New oral anticoagulants: an emergency department overview. Emergency medicine Australasia : EMA, 2013, Volume: 25, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Australia; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial. BMC family practice, 2014, Oct-25, Volume: 15 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism	2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. Journal of medical economics, 2015, Volume: 18, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Costs and Cost Analysis; Dabigatran; Health Expenditures; Hemorrhage; Humans; Models, Econometric; Myocardial Infarction; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; United States; Venous Thromboembolism; Warfarin	2015
[Extended options of anticoagulant treatment in thromboembolism]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:11 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Czech Republic; Dabigatran; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2014
[Use of dabigatran etexilate for treatment of deep vein thrombosis and pulmonary artery thromboembolism]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2015, Volume: 21, Issue:2 Topics: Adult; Angiography; Benzimidazoles; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Echocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Pulmonary Embolism; Pyridines; Russia; Thrombophilia; Treatment Outcome; Venous Thrombosis	2015
Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data. PloS one, 2015, Volume: 10, Issue:8 Topics: Anticoagulants; Antithrombins; Cost Savings; Cost-Benefit Analysis; Dabigatran; Decision Support Techniques; Health Resources; Humans; Netherlands; Pulmonary Embolism; Quality-Adjusted Life Years; Retrospective Studies; Venous Thrombosis; Vitamin K	2015
The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK. Thrombosis and haemostasis, 2015, Volume: 114, Issue:4 Topics: Acute Disease; Anticoagulants; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Drug Costs; Hemorrhage; Humans; Kaplan-Meier Estimate; Models, Economic; Pulmonary Embolism; Quality-Adjusted Life Years; State Medicine; Time Factors; Treatment Outcome; United Kingdom; Venous Thromboembolism; Venous Thrombosis; Warfarin	2015
Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug. Prescrire international, 2015, Volume: 24, Issue:161 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thrombosis; Warfarin	2015
Management of acute pulmonary embolism. British journal of hospital medicine (London, England : 2005), 2015, Volume: 76, Issue:10 Topics: Acute Disease; Age Factors; Ambulatory Care; Anticoagulants; Antithrombins; Comorbidity; Dabigatran; Disease Management; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hospitalization; Humans; Male; Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thrombolytic Therapy; Tissue Plasminogen Activator; Vena Cava Filters; Warfarin	2015
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1 Topics: Animals; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Disease Models, Animal; Disease Progression; Embolization, Therapeutic; Female; Femoral Vein; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Lung; Mice; Mice, Inbred C57BL; Microscopy, Video; Pulmonary Embolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis	2016
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran. Thrombosis research, 2016, Volume: 138 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Platelets; Dabigatran; Female; Humans; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Receptors, Thrombin; Rivaroxaban; Venous Thrombosis	2016
Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring. Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:3 Topics: Alcoholism; Anticoagulants; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Overdose; Female; Half-Life; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Middle Aged; Monitoring, Physiologic; Pulmonary Embolism; Risk Factors; Young Adult	2016
[Your patient needs an antithrombotic drug. Venous thrombosis of the leg: how and how long anticoagulation?]. MMW Fortschritte der Medizin, 2015, Oct-08, Volume: 157, Issue:17 Topics: Administration, Oral; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Fibrinolytic Agents; General Practice; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thrombosis	2015
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. Pharmacotherapy, 2016, Volume: 36, Issue:2 Topics: Anticonvulsants; Antithrombins; Dabigatran; Drug Interactions; Drug Monitoring; Humans; Male; Middle Aged; Phenytoin; Pulmonary Embolism; Secondary Prevention; Seizures; Treatment Outcome; Venous Thrombosis	2016
Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura. Thrombosis research, 2016, Volume: 148 Topics: Antithrombins; Dabigatran; Humans; Male; Middle Aged; Platelet Count; Pulmonary Artery; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recurrence	2016
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thrombosis and haemostasis, 2017, 01-26, Volume: 117, Issue:2 Topics: Acute Disease; Anticoagulants; Antithrombins; Blood Coagulation; Cross-Sectional Studies; Dabigatran; Hemorrhage; Humans; Prospective Studies; Pulmonary Embolism; Research Design; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2017
Development of Left Atrial Thrombus After Coadministration of Dabigatran Etexilate and Phenytoin. The Canadian journal of cardiology, 2017, Volume: 33, Issue:4 Topics: Aged; Antithrombins; Cytochrome P-450 CYP1A2 Inducers; Dabigatran; Drug Interactions; Drug Therapy, Combination; Echocardiography, Transesophageal; Heart Atria; Heart Diseases; Humans; Male; Phenytoin; Pulmonary Embolism; Thrombosis	2017
[Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Electric Countershock; Emergency Service, Hospital; Factor Xa Inhibitors; Hemorrhage; Humans; Intensive Care Units; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombin; Thromboembolism; Vitamin K	2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER Journal of thrombosis and thrombolysis, 2017, Volume: 43, Issue:4 Topics: Adult; Aged; Clinical Trials as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Embolism; Stroke; Venous Thromboembolism; Venous Thrombosis; Warfarin	2017
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin. The American journal of gastroenterology, 2017, Volume: 112, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Incidence; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin	2017
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]. Der Internist, 2017, Volume: 58, Issue:7 Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Dabigatran; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Partial Thromboplastin Time; Pulmonary Embolism; Recurrence; Thromboembolism; Venous Thrombosis	2017
Warfarin or not. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:4 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Pulmonary Embolism; Venous Thromboembolism; Warfarin	2010
[New anticoagulants in the prevention and treatment of venous thromboembolism]. Orvosi hetilap, 2011, Jun-19, Volume: 152, Issue:25 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Costs; Drugs, Investigational; Factor Xa Inhibitors; Humans; Hungary; Morpholines; Oligosaccharides; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism	2011
[Pharmacologic heterogeneity of new anticoagulants]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Approval; Humans; Kidney; Liver; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; United States; United States Food and Drug Administration	2011
[New treatments for venous thromboembolic disease]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis; Warfarin	2011
Acute adrenal failure following anticoagulation with dabigatran after hip replacement and thrombolysis for massive pulmonary embolism. BMJ case reports, 2013, Jan-11, Volume: 2013 Topics: Adrenal Gland Diseases; Adrenal Insufficiency; Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Female; Fibrinolytic Agents; Hemorrhage; Humans; Pulmonary Embolism; Tissue Plasminogen Activator	2013
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement]. Revista espanola de salud publica, 2012, Volume: 86, Issue:6 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Budgets; Cost Control; Dabigatran; Enoxaparin; Female; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Humans; Morpholines; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Spain; State Medicine; Thiophenes; Venous Thromboembolism	2012
Agents to control bleeding show promise. JAMA, 2007, Jan-24, Volume: 297, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Hematologic Agents; Humans; Oligosaccharides; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Receptors, Thrombopoietin; Rituximab; Venous Thrombosis	2007
[Update in hospital internal medicine (2007): a selection]. Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142 Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis	2008